Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Kyung Taek Hong, MD, Soyoung Lee, Jaeseong Oh, Jung Yoon Choi, MD, Hee Young Shin, MD PhD, Kyung-Sang Yu, MD PhD, Hyoung Jin Kang, MD PhD

Blood (2019) 134 (Supplement_1): 3594.

https://doi.org/10.1182/blood-2019-125266

Published: 2019

Journal Articles

Risk Factors and Characteristics of CRS in CAR-T Treatment

Yan Zhiling, MD, Zhang Huanxin, MD, Ying Wang, Jiang Cao, MD, Jianlin Qiao, PhD, Deipeng Li, MD, Bin Pan, MD, Qingyun Wu, PhD, Zhenyu Li, MD, Kailin Xu, MD

Blood (2019) 134 (Supplement_1): 4462.

https://doi.org/10.1182/blood-2019-129777

Published: 2019

Journal Articles

Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML

Dongwoo Kang, PhD, Julie Passarell, MA, Malaz A Abutarif, PhD, Jeanne Mendell, PhD MPH, Ophelia Yin, PhD

Blood (2019) 134 (Supplement_1): 1263.

https://doi.org/10.1182/blood-2019-122582

Published: 2019

Journal Articles

Excretion and Distribution of the 60-kDa PEG Moiety Used in BAY 94-9027 in Male Wistar Rats

Andreas Baumann, Thomas Schwarz, Frank Hucke, Isabel Piel, Steffen Sandmann

Blood (2017) 130 (Supplement 1): 3674.

https://doi.org/10.1182/blood.V130.Suppl_1.3674.3674

Published: 2017

Journal Articles

Exploratory Pharmacokinetic/Pharmacodynamic and Tolerability Study of BCMAxCD3 in Cynomolgus Monkeys

Suzette Girgis, PhD BPharm, MS, Shoba Shetty, PhD, Trina Jiao, MS, Chidozie Amuzie, Dan Weinstock, Rebecca Grimme Watson, Joyce Ford, Kodandaram Pillarisetti, Eric Baldwin, Kevin Bellew

Blood (2016) 128 (22): 5668.

https://doi.org/10.1182/blood.V128.22.5668.5668

Published: 2016

Journal Articles

Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Blood (2016) 128 (22): 221.

https://doi.org/10.1182/blood.V128.22.221.221

Published: 2016

Journal Articles

Felipe Samaniego

Neeraj Jain, PhD, Lalit Sehgal, PhD, R. Eric Davis, MD, Stephen Joseph Shuttleworth, PhD, Felipe Samaniego, MD

Blood (2016) 128 (22): 5145.

https://doi.org/10.1182/blood.V128.22.5145.5145

Published: 2016

Journal Articles

Population Pharmacokinetics of Crenolanib, a Type I FLT3 Inhibitor, in Patients with Relapsed/Refractory AML

John Carl Panetta, Sharyn D Baker, PharmD, PhD, Hagop M. Kantarjian, MD, Clinton Stewart, Pharm.D., Blake Pond, MS, Meghan Macaraeg, BS, Tolu Makinde, PhD, Sheetal Vali, PhD, Naval Daver, MD, Abhijit Ramachandran, MS, Robert Collins, MD, Jorge E. Cortes, MD

Blood (2015) 126 (23): 3695.

https://doi.org/10.1182/blood.V126.23.3695.3695

Published: 2015

Journal Articles

Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins

Blood (2014) 124 (2): 167–175.

https://doi.org/10.1182/blood-2014-02-555953

Published: 2014

Includes: Supplemental data

Journal Articles

Integrating in vitro sensitivity and dose-response slope is predictive of clinical response to ABL kinase inhibitors in chronic myeloid leukemia

Vladimir Vainstein, Christopher A. Eide, Thomas O’Hare, Ofir Shukron, Brian J. Druker

Blood (2013) 122 (19): 3331–3334.

https://doi.org/10.1182/blood-2012-08-452409

Published: 2013

Includes: Supplemental data

Journal Articles

Single Oral Doses of a Novel Thrombopoietin Mimetic ONO-7746 Increase Platelet Counts In Healthy Subjects

Thomas L Hunt, MD, Ph.D, Ming Q. Lu, MD, PhD, Yasushi Kawasaki, MS, John P. Hall, BS, MBA, Junji Komaba, Ph.D, Masahiro Takeuchi, MS, Takuya Imamura, MS, David J. Kuter, MD, DPhil

Blood (2011) 118 (21): 4827.

https://doi.org/10.1182/blood.V118.21.4827.4827

Published: 2011

Journal Articles

Pharmacokinetics of RO5072759 (GA101) In Patients with Relapsed/Refractory CD20 + Malignant Disease (Phase I/II Study BO20999)

Georgina Meneses-Lorente, PhD, David Carlile, PhD, Joe Birkett, PhD, Michael K. Wenger, MD, Guillaume Cartron, MD, PhD, Franck Morschhauser, MD, PhD, Gilles Andre Salles, MD, PhD

Blood (2010) 116 (21): 1833.

https://doi.org/10.1182/blood.V116.21.1833.1833

Published: 2010

Journal Articles

Facilitation of Osteoblast Differentiation by ATF-4 Accumulation through Proteasome Inhibition.

Shingen Nakamura, Masahiro Abe, Qu Cui, Ayako Nakano, Asuka Oda, Hiroe Amou, Akishige Ikegame, Takeshi Harada, Masahiro Hiasa, Hirokazu Miki, Kumiko Kagawa, Kyoko Takeuchi, Kenichiro Yata, Shuji Ozaki, Toshio Matsumoto

Blood (2009) 114 (22): 1823.

https://doi.org/10.1182/blood.V114.22.1823.1823

Published: 2009

Journal Articles

Optimal Post-Dose Levels of Cyclosporine A at a Higher Peak Concentration Are Correlated with the Area Under the Concentration-Time Curve of Twice-Daily Infusion and Oral Administration in Allogeneic Hematopoietic Stem Cell Transplantation.

Yasuyuki Inoue, MD, Tasuku Saito, MD, Kohei Ogawa, Yuji Nishio, Seiju Kosugi, Yoshinori Suzuki, MD, Yasushi Shibuya, Masayuki Kato, MD, Masatomo Takahashi, MD, Ikuo Miura, MD

Blood (2009) 114 (22): 4656.

https://doi.org/10.1182/blood.V114.22.4656.4656

Published: 2009

Journal Articles

Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration.

Chenthil Rathnasabapathy, MD, Kathleen West, Ph.D, Gerald Fetterly, Ph.D, Minocher Battiwalla, MD, Shannon L Smiley, MD, Theresa Hahn, PhD, Karen Brown, NP, Karen Arnold, NP, Margaret Syta, NP, Pamela Paplham, NP, Joann Liu, NP, Philip L. McCarthy, MD

Blood (2009) 114 (22): 2276.

https://doi.org/10.1182/blood.V114.22.2276.2276

Published: 2009

Journal Articles

Aplidin Cardiac Safety Analysis.

Arturo Soto-Matos, MD, Sergio Szyldergemajn, MD, Javier Gomez, PhD, Sonia Extremera, BS, Bernardo Miguel-Lillo, PhD, Vicente Alfaro, PhD, Cinthya Coronado, MD, Pilar Lardelli, MD, Elena Roy, MD, Claudia S. Corrado, MD, Alejandro Yovine, MD, Carmen Kahatt, MD

Blood (2009) 114 (22): 4820.

https://doi.org/10.1182/blood.V114.22.4820.4820

Published: 2009

Journal Articles

Pharmacokinetic Results from a Phase 1 Study of a Multi-Targeted Tyrosine Kinase Inhibitor, ABT-869, in Patients with Refractory or Relapsed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Wendy Stock, MD, Karen WL Yee, MD, Eunice S. Wang, MD, Sari Enschede, MD, Joyce Steinberg, MD, Rod Humerickhouse, MD, PhD, Qin Qin, PhD, Jiang Qian, PhD, Yi-Lin Chiu, PhD, Neeraj Gupta, PhD, Rajendra Pradhan, PhD

Blood (2008) 112 (11): 4008.

https://doi.org/10.1182/blood.V112.11.4008.4008

Published: 2008

Journal Articles

Combination of a Spicamycin Analogue KRN5500 and Chemotherapeutic Agents Synergistically Enhances Their Cytotoxicity in Human Myeloma Cells.

Hirokazu Miki, MD, Shuji Ozaki, MD, Osamu Tanaka, MD, Shiro Fujii, MD, Shingen Nakamura, MD, Ai Mihara, MD, Kumiko Kagawa, MD, Jin Asano, MD, Kyoko Takeuchi, MD, Kenichiro Yata, MD, Toshihiro Hashimoto, MD, Masahiro Abe, MD, Toshio Matsumoto, MD

Blood (2007) 110 (11): 4783.

https://doi.org/10.1182/blood.V110.11.4783.4783

Published: 2007

Journal Articles

A Phase I Trial of CHIR-258, a Multitargeted RTK Inhibitor, in Acute Myeloid Leukemia (AML).

Gareth J. Morgan, A. Parker, J. Cavet, J. Cavenaugh, C. Heise, F. Garzon

Blood (2005) 106 (11): 2794.

https://doi.org/10.1182/blood.V106.11.2794.2794

Published: 2005

Journal Articles

In Vitro Antisickling Effects of Novel Pyridyl Derivatives with Enhanced Potency.

Osheiza Y. Abdulmalik, DVM, Martin K. Safo, PhD, Gajanan Joshi, PhD, Jisheng Yang, Qiukan Chen, Daniel Obeng, Donald J. Abraham, PhD, Toshio Asakura, MD, PhD

Blood (2005) 106 (11): 2347.

https://doi.org/10.1182/blood.V106.11.2347.2347

Published: 2005

NARROW

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Risk Factors and Characteristics of CRS in CAR-T Treatment

Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML

Excretion and Distribution of the 60-kDa PEG Moiety Used in BAY 94-9027 in Male Wistar Rats

Exploratory Pharmacokinetic/Pharmacodynamic and Tolerability Study of BCMAxCD3 in Cynomolgus Monkeys

Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Felipe Samaniego

Population Pharmacokinetics of Crenolanib, a Type I FLT3 Inhibitor, in Patients with Relapsed/Refractory AML

Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins

Integrating in vitro sensitivity and dose-response slope is predictive of clinical response to ABL kinase inhibitors in chronic myeloid leukemia

Single Oral Doses of a Novel Thrombopoietin Mimetic ONO-7746 Increase Platelet Counts In Healthy Subjects

Pharmacokinetics of RO5072759 (GA101) In Patients with Relapsed/Refractory CD20 + Malignant Disease (Phase I/II Study BO20999)

Facilitation of Osteoblast Differentiation by ATF-4 Accumulation through Proteasome Inhibition.

Optimal Post-Dose Levels of Cyclosporine A at a Higher Peak Concentration Are Correlated with the Area Under the Concentration-Time Curve of Twice-Daily Infusion and Oral Administration in Allogeneic Hematopoietic Stem Cell Transplantation.

Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration.

Aplidin Cardiac Safety Analysis.

Pharmacokinetic Results from a Phase 1 Study of a Multi-Targeted Tyrosine Kinase Inhibitor, ABT-869, in Patients with Refractory or Relapsed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Combination of a Spicamycin Analogue KRN5500 and Chemotherapeutic Agents Synergistically Enhances Their Cytotoxicity in Human Myeloma Cells.

A Phase I Trial of CHIR-258, a Multitargeted RTK Inhibitor, in Acute Myeloid Leukemia (AML).

In Vitro Antisickling Effects of Novel Pyridyl Derivatives with Enhanced Potency.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only